abrdn Life Sciences Investors Shares of Beneficial Interest (HQL)
Revenue
$48.07M
Quarterly · Period ending: · USD
HQL Revenue
Latest reported$48.07Mperiod ending
Latest reported$48.07Mperiod ending
HQL Quarterly Revenue ($210.00K → $48.07M)
Quarterly revenue
High-resolution chart · PNG
HQL revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Revenue (USD) |
|---|---|
| 48,070,280 | |
| 11,633,626 | |
| 18,198,713 | |
| 1,914,720 | |
| 2,065,264 | |
| 29,564,128 | |
| 1,929,271 | |
| 21,690,954 | |
| 10,171,443 | |
| 15,979,471 | |
| 29,032,617 | |
| 16,499,019 | |
| 22,572,629 | |
| 1,314,021 | |
| 1,126,565 | |
| 988,762 | |
| 997,061 | |
| 891 | |
| 791 | |
| 722 | |
| 716 | |
| 835 | |
| 488 | |
| 412 | |
| 465 | |
| 278 | |
| 120 | |
| 1,457,954 | |
| 686,551 | |
| 285,000 | |
| 285,000 | |
| 910,000 | |
| 910,000 | |
| 230,000 | |
| 230,000 | |
| 835,000 | |
| 835,000 | |
| 1,440,000 | |
| 1,440,000 | |
| 1,150,000 | |
| 1,150,000 | |
| 445,000 | |
| 445,000 | |
| 160,000 | |
| 160,000 | |
| 305,000 | |
| 305,000 | |
| 470,000 | |
| 470,000 | |
| 885,000 | |
| 885,000 | |
| 70,000 | |
| 70,000 | |
| 160,000 | |
| 160,000 | |
| 210,000 | |
| 210,000 |